XML 27 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Based Compensation
9 Months Ended
Sep. 30, 2016
Share Based Compensation [Abstract]  
Share Based Compensation
9.
Share Based Compensation

We maintain share based payment plans that include a non-employee director stock purchase plan and a long-term incentive plan that permits the issuance of share based compensation, including stock options and non-vested share awards. The long-term incentive plan, which is shareholder approved, permits the grant of additional share based awards for up to 0.2 million shares of common stock as of September 30, 2016.  The non-employee director stock purchase plan permits the issuance of additional share based payments for up to 0.2 million shares of common stock as of September 30, 2016. Share based awards and payments are measured at fair value at the date of grant and are expensed over the requisite service period. Common shares issued upon exercise of stock options come from currently authorized but unissued shares.

During each first quarter period of 2016 and 2015, pursuant to our long-term incentive plan, we granted 0.07 million shares of restricted stock and 0.03 million performance stock units (“PSU”) to certain officers.  The shares of restricted stock and PSUs cliff vest after a period of three years.  The performance feature of the PSUs is based on a comparison of our total shareholder return over the three year period starting on the grant date to the total shareholder return over that period for a banking index of our peers.  In addition, we issued 0.02 million PSUs and 0.01 million shares of restricted stock to certain officers and employees during the third quarter of 2016.  The PSUs cliff vest after four and five year periods and the restricted stock cliff vests after one and four year periods.

Our directors may elect to receive a portion of their quarterly cash retainer fees in the form of common stock (either on a current basis or on a deferred basis pursuant to the non-employee director stock purchase plan referenced above). Shares equal in value to that portion of each director’s fees that he or she has elected to receive in stock are issued each quarter and vest immediately.  We issued 0.006 million shares and 0.004 million shares to directors during the first nine months of 2016 and 2015, respectively and expensed their value during those same periods.

Total compensation expense recognized for grants pursuant to our long-term incentive plan was $0.3 million and $1.1 million during the three and nine month periods ended September 30, 2016, respectively, and was $0.4 million and $1.1 million during the same periods in 2015, respectively.  The corresponding tax benefit relating to this expense was $0.1 million and $0.4 million for the three and nine month periods ended September 30, 2016, respectively and $0.1 million and $0.4 million for the same periods in 2015. Total expense recognized for non-employee director share based payments was $0.03 million and $0.09 million during the three and nine month periods ended September 30, 2016, respectively, and was $0.02 million and $0.05 million during the same periods in 2015, respectively.  The corresponding tax benefit relating to this expense was $0.01 million and $0.03 million for the three and nine month periods ended September 30, 2016, respectively and $0.01 million and $0.02 million during the same respective periods in 2015.

At September 30, 2016, the total expected compensation cost related to non-vested stock options, restricted stock and PSUs not yet recognized was $2.2 million.  The weighted-average period over which this amount will be recognized is 2.2 years.
 
A summary of outstanding stock option grants and related transactions follows:

 
Number of
Shares
  
Average
Exercise
Price
  
Weighted-
Average
Remaining
Contractual
Term (Years)
  
Aggregated
Intrinsic
Value
 
           
(In thousands)
 
Outstanding at January 1, 2016
  
235,596
  
$
4.94
       
Granted
  
-
           
Exercised
  
(16,912
)
  
3.78
       
Forfeited
  
(664
)
  
6.42
       
Expired
  
(2,300
)
  
3.54
       
Outstanding at September 30, 2016
  
215,720
  
$
5.04
   
5.33
  
$
2,544
 
                 
Vested and expected to vest at September 30, 2016
  
215,720
  
$
5.04
   
5.33
  
$
2,544
 
Exercisable at September 30, 2016
  
215,720
  
$
5.04
   
5.33
  
$
2,544
 

A summary of outstanding non-vested restricted stock, restricted stock units and PSUs and related transactions follows:

  
Number
of Shares
  
Weighted-
Average
Grant Date
Fair Value
 
Outstanding at January 1, 2016
  
261,981
  
$
11.29
 
Granted
  
121,660
   
15.05
 
Vested
  
(107,795
)
  
7.92
 
Forfeited
  
(4,924
)
  
13.24
 
Outstanding at September 30, 2016
  
270,922
  
$
14.28
 

Certain information regarding options exercised during the periods follows:

  
Three Months Ended
September 30,
  
Nine Months Ended
September 30,
 
  
2016
  
2015
  
2016
  
2015
 
             
Intrinsic value
 
$
9
  
$
71
  
$
186
  
$
314
 
Cash proceeds received
 
$
5
  
$
23
  
$
64
  
$
105
 
Tax benefit realized
 
$
3
  
$
25
  
$
65
  
$
110